All New issues
Desjardins Fixed Coupon Notes (Maturity-Monitored Barrier), US Market ETF, Series 101
$1.00;
- Non-Principal Protected Notes
Additional Informations
Issuer: | Fédération des caisses Desjardins du Québec |
---|---|
Securities Offered: | Desjardins Fixed Coupon Notes (Maturity-Monitored Barrier), US Market ETF, Series 101 |
Issue Price: | $100 per Note |
Minimum: | $ 1,000 (10 notes) |
Reference Index: | The notes are linked to the price return of the units of the SPDR S&P 500 ETF Trust, (the “reference asset”), an exchange traded fund. |
Issuance Date: | September 6, 2024 |
Maturity Date: | September 6, 2030 |
Settlement date: | Transaction date plus 2 days. **All purchases are closed without the possibility of cancellation ** Please refer to Information Statement Document, Right of cancellation. |
RRSP & TFSA Eligibility: | Yes |
Participation rate: | Participation rate applicable to the negative reference portfolio return below the barrier. Is equal to 100.00% |
Term: | 6 an(s) |
Maximum return: | Maximum return is equal to the sum of fixed coupons : 30.00 % |
Fixed Coupon Payments: | Fixed coupons paid quarterly corresponding to 1.25 % (equivalent to 5.00 % annually) |
Barrier Level: | -30% |
Protection of capital | The capital is not protected. |
Early Trading Fees: | This fee goes from 3.50 %, initially to 0% after 360 days. |
Secondary Market: | DSN00867 |
Commission received from the Issuer: | Desjardins online brokerage will receive from the issuer a remuneration of $2.40 for each note sold (equivalent to 2.40 % of the principal amount) |
Subscription close: | August 30, 2024, noon. Books can close without any further notice. |
Offering Document: | For more detailed information please refer to the prospectus. |
Investment highlights: | To view the Investment highlights please refer to this document. |
The content of this page is transmitted strictly for informational purposes. Investments must be selected in accordance with the investor's respective objectives. Desjardins Online Brokerage does not issue any recommendations or endorsements concerning any particular product, its potential value or appropriateness, or any specific strategy. It is highly recommended to read the prospectus before making any type of investment.